Lipomic profiling in drug discovery, development and clinical trial evaluation

Area of Science:

• Biochemistry
• Metabolomics
• Pathology

Background:

• Lipid metabolism is integral to numerous diseases and drug responses.
• Subtle, long-term shifts in multiple lipid metabolites often precede disease onset, evading standard biomarker detection.
• Understanding lipid alterations is critical for disease diagnosis and therapeutic development.

Purpose of the Study:

• To highlight the role of lipid metabolism dysregulation in disease progression and drug response.
• To introduce the application of 'omics technologies in lipid analysis.
• To emphasize the potential of integrated lipid knowledge for drug discovery and development.

Main Methods:

• Application of 'omics principles to lipid studies.
• Development of comprehensive, high-throughput lipid assays.
• Establishment of centralized reference databases for lipid information.

Main Results:

• 'Omics approaches are yielding integrated and actionable knowledge of lipids in relation to pathology.
• Advanced analytical tools and databases are becoming available for lipid research.
• These advancements facilitate a deeper understanding of drug effects on lipid metabolism.

Conclusions:

• Dysregulated lipid metabolism is a key factor in disease and adverse drug reactions.
• 'Omics technologies and integrated databases are transforming lipid research.
• Enhanced knowledge of lipid metabolism will improve drug discovery, development, and testing.